Mivacurium Cl (Mivacurium Cl)
Overview of Mivacurium Cl
Mivacurium (Cl) is a benzylisoquinolinium, a competative neuromuscular blocker similar to atracurium. Mivacurium (Cl) is used to produce muscle relaxation in general anaesthesia for surgical procedures and also to assist mechanical ventilation. It has a short duration of action than most other competitive neuromuscular blockers. Mivacurium (Cl) is metabolised by plasma cholinestarase and muscle paralysis is prolonged in individuals deficient in this enzyme. Mivacurium (Cl) is not associated with parasympatholytic or ganglionic blockade although histamine release may occur, perticularly with rapid injection.
Indication of Mivacurium Cl
Mivacurium Cl is primarily indicated in conditions like Adjunct to anesthesia, Muscle relaxation, Muscle relaxation (short duration) for surgery.
Contraindication of Mivacurium Cl
Mivacurium (Cl) is contraindicated in conditions like Hypersensitivity,Cholinesterase deficiency.
Side Effects of Mivacurium Cl
Mivacurium (Cl) produces potentially life-threatening effects which include Hypotension, Bronchospasm, Bronchospasm, Erythema, Prolongation of neuromuscular blockade. which are responsible for the discontinuation of Mivacurium (Cl) therapy.,The signs and symptoms that are produced after the acute overdosage of Mivacurium (Cl) include Hypotension, Apnea, Paralysis of respiratory muscle, Flaccid paralysis..
Precautions of Mivacurium Cl
Use with caution in patients with bronchial asthma. Exercise special caution, especially when histamine release would be hazardous, especially in patients with significant cardiovascular diseases. It should be used with cuation in pateints with plasma cholinesterase deficiency.